Search Results - Ina Oehme
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells by Nathalie Fiegler, Sonja Textor, Annette Arnold, Alexander Rölle, Ina Oehme, Kai Breuhahn, Gerhard Moldenhauer, Mathias Witzens‐Harig, Adelheid Cerwenka
Published 2013Artigo -
6
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells by Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Dina ElHarouni, Ina Oehme, Olaf Witt, Till Milde, Jonas Ecker
Published 2024Artigo -
7
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis by Ina Oehme, Hedwig E. Deubzer, Dennis Wegener, Diana Pickert, Jan-Peter Linke, Barbara Hero, Annette Kopp‐Schneider, Frank Westermann, Scott Ulrich, Andreas von Deimling, Matthias Fischer, Olaf Witt
Published 2008Artigo -
8
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated by Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, Aubry K. Miller
Published 2019Artigo -
9
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance by Corinna Bingel, E Koeneke, Johannes Ridinger, Annika Bittmann, Martin Sill, Heike Peterziel, Jagoda K. Wrobel, I Rettig, Till Milde, Uta Fernekorn, Frank Weise, Andreas Schober, Olaf Witt, Ina Oehme
Published 2017Artigo -
10
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance by Johannes Ridinger, E Koeneke, Fiona R. Kolbinger, Katharina Koerholz, Siavosh Mahboobi, Lars Hellweg, Nikolas Gunkel, Aubry K. Miller, Heike Peterziel, Peter Schmezer, Anne Hamacher‐Brady, Olaf Witt, Ina Oehme
Published 2018Artigo -
11
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins by Melisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz, Michelle Lazenby, Caroline Alvares, Matthias Schmidt, Walburgis Brenner, Sara Najafi, Ina Oehme, Christoph Hieber, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver H. Krämer
Published 2024Artigo -
12
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth by Till Milde, Ina Oehme, Andrey Korshunov, Annette Kopp‐Schneider, Marc Remke, Paul A. Northcott, Hedwig E. Deubzer, Marco Lodrini, Michael D. Taylor, Andreas von Deimling, Stefan M. Pfister, Olaf Witt
Published 2010Artigo -
13
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation by I Rettig, E Koeneke, Franziska Trippel, Wolf Mueller, Jürgen Burhenne, Annette Kopp‐Schneider, Johannes Fabian, Andreas Schober, Uta Fernekorn, Andreas von Deimling, Hedwig E. Deubzer, Till Milde, Olaf Witt, Ina Oehme
Published 2015Artigo -
14
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity by Salma Darwish, Ehab Ghazy, Tino Heimburg, Daniel Herp, Patrik Zeyen, Rabia Salem-Altintas, Johannes Ridinger, Dina Robaa, Matthias Schmidt, Frank Erdmann, Matthias Schmidt, Christophe Romier, Manfred Jung, Ina Oehme, Wolfgang Sippl
Published 2022Artigo -
15
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors by Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md. Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal, Alexander Kühn, Mark Hartmann, Dieter Weichenhan, Manfred Jung, Christoph Plass
Published 2018Revisão -
16
Nestin Expression Identifies Ependymoma Patients with Poor Outcome by Till Milde, Thomas Hielscher, Hendrik Witt, Marcel Kool, Stephen C. Mack, Hedwig E. Deubzer, Ina Oehme, Marco Lodrini, Axel Benner, Michael D. Taylor, Andreas von Deimling, Andreas E. Kulozik, Stefan M. Pfister, Olaf Witt, Andrey Korshunov
Published 2012Artigo -
17
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma by Jonas Ecker, Ina Oehme, Ralph Mazitschek, Andrey Korshunov, Marcel Kool, Thomas Hielscher, Judit Kiss, Florian Selt, Carina Konrad, Marco Lodrini, Hedwig E. Deubzer, Andreas von Deimling, Andreas E. Kulozik, Stefan M. Pfister, Olaf Witt, Till Milde
Published 2015Artigo -
18
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells by Patrik Zeyen, Yanira Zeyn, Daniel Herp, Fereshteh Mahmoudi, Talha Z. Yesiloglu, Frank Erdmann, Matthias Schmidt, Dina Robaa, Christophe Romier, Johannes Ridinger, Corey J. Herbst‐Gervasoni, D.W. Christianson, Ina Oehme, Manfred Jung, Oliver H. Krämer, Wolfgang Sippl
Published 2022Artigo -
19
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines by Merve Kasan, Florian H. Geyer, Jana Siebenlist, Martin Sill, Rupert Öllinger, Tobias Faehling, Enrique de Álava, Didier Surdez, Uta Dirksen, Ina Oehme, Katia Scotlandi, Olivier Delattre, Martina Müller‐Nurasyid, Roland Rad, Konstantin Strauch, T. Grünewald, Florencia Cidre‐Aranaz
Published 2025Artigo -
20
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma by Marco Lodrini, Ina Oehme, Christina I. Schroeder, Till Milde, Marie C. Schier, Annette Kopp‐Schneider, Johannes H. Schulte, Matthias Fischer, Katleen De Preter, Filip Pattyn, M. Castoldi, Martina U. Muckenthaler, Andreas E. Kulozik, Frank Westermann, Olaf Witt, Hedwig E. Deubzer
Published 2013Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Gene
Biochemistry
Genetics
Histone
Histone deacetylase
Cell biology
Medicine
Cell culture
Chemistry
Cancer
Gene knockdown
Apoptosis
Glioma
Neuroblastoma
Pathology
Pharmacology
Downregulation and upregulation
Enzyme
Epigenetics
HDAC10
HDAC8
In vivo
Internal medicine
Astrocytoma
Biotechnology
Cell
Computational biology
DNA